title: Complementation of yeast Arc1p by the p43 component of the human multisynthetase complex does not require its association with yeast MetRS and GluRS.
abstract: Yeast Arc1p, human p43 and plant methionyl-tRNA synthetase (MetRS) possess an EMAPII-like domain capable of non-specific interactions with tRNA. Arc1p interacts with MetRS (MES1) and GluRS and operates as a tRNA-interacting factor (tIF) in trans of these two synthetases. In plant MetRS, the EMAPII-like domain is fused to the catalytic core of the synthetase and acts as a cis-acting tIF for aminoacylation. We observed that the catalytic core of plant MetRS expressed from a centromeric plasmid cannot complement a yeast arc1(-) mes1(-) strain. Overexpression of the mutant enzyme from a high-copy number plasmid restored cell growth, suggesting that deletion of its C-terminal tIF domain was responsible for the poor aminoacylation efficiency of that enzyme in vivo. Accordingly, expression of full-size plant MetRS from a centromeric plasmid, but also of fusion proteins between its catalytic core and the EMAPII-like domains of yeast Arc1p or of human p43 restored cell viability. These data showed that homologous tIF domains from different origins are interchangeable and may act indifferently in trans or in cis of the catalytic domain of a synthetase. Unexpectedly, co-expression of Arc1p with the catalytic core of plant MetRS restored cell viability as well, even though Arc1p did not associate with plant MetRS. Because Arc1p also interacts with yeast GluRS, restoration of cell growth could be due at least in part to its role of cofactor for that enzyme. However, co-expression of human p43, a tIF that did not associate with plant MetRS or with yeast GluRS and MetRS, also restored cell viability of a yeast strain that expressed the catalytic core of plant MetRS. These results show that p43 and Arc1p are able to facilitate tRNA aminoacylation in vivo even if they do not interact physically with the synthetases. We propose that p43/Arc1p may be involved in sequestering tRNAs in the cytoplasm of eukaryotic cells, thereby increasing their availability for protein synthesis.
authors.affiliation: Laboratoire d'Enzymologie et Biochimie Structurales, UPR 9063 du Centre National de la Recherche Scientifique, 91190 Gif-sur-Yvette, France.
authors.forename: Marie-Pierre
authors.initials: MP
authors.lastname: Golinelli-Cohen
authors.forename: Adriana
authors.initials: A
authors.lastname: Zakrzewska
authors.forename: Marc
authors.initials: M
authors.lastname: Mirande
mesh_terms: D002384:Catalysis; D002455:Cell Division; D016207:Cytokines / Q000378:metabolism*; D005975:Glutamate-tRNA Ligase / Q000378:metabolism*; D006801:Humans; D008718:Methionine-tRNA Ligase / Q000378:metabolism*; D009363:Neoplasm Proteins / Q000378:metabolism*; D012275:Oryza / Q000378:metabolism; D016601:RNA-Binding Proteins / Q000378:metabolism*; D011993:Recombinant Fusion Proteins; D029701:Saccharomyces cerevisiae Proteins / Q000378:metabolism*; D015003:Yeasts
chemical_list: C102145:ARC1 protein, S cerevisiae; D016207:Cytokines; D009363:Neoplasm Proteins; D016601:RNA-Binding Proteins; D011993:Recombinant Fusion Proteins; D029701:Saccharomyces cerevisiae Proteins; C077219:small inducible cytokine subfamily E, member 1; D008718:Methionine-tRNA Ligase; D005975:Glutamate-tRNA Ligase